The prevalence of HIV in 2015 for incarcerated individuals was markedly higher than the 0.4% HIV prevalence in the general United States population. In addition, HCV infection disproportionately affects individuals in correctional institutions. Along with these two diseases, COVID-19 has affected corrections in rates greatly exceeding those in the community. Individuals with serious underlying medical conditions are at greater risk of severe illness from COVID-19. Given these disproportionate numbers, it is critical that correctional health professionals have the best information on screening, treatment, and prevention of HIV, HCV, and COVID-19.
- Explain why correctional populations have higher rates of HIV, HCV, and COVID-19
- Identify comorbidities between HIV, HCV, and COVID-19 and areas of highest concern
- Discuss screening, testing, and treatment for HIV, HCV, and COVID-
Sponsored by an independent educational grant from Gilead Sciences
1 hour of CE. Refreshments and hors d'oeuvres will be served.